Hold onto your hats, baseball fans, because there’s a potential mega-trade brewing that could shake the MLB landscape more than any Skubal deal ever could. But here’s where it gets controversial: the Los Angeles Dodgers might not be eyeing Tarik Skubal as their next big move. Instead, all signs point to Sandy Alcantara as the real game-changer—a pitcher who’s been through the wringer but is now showing glimpses of his former dominance. Let’s dive into why this trade could be a steal for the Dodgers and a missed opportunity for the Marlins.
First, let’s address the elephant in the room: Tarik Skubal. The Detroit Tigers aren’t in a rush to trade him, especially not before the deadline. While his $32 million contract in its final year has sparked rumors, Skubal isn’t the most logical target for the Dodgers. Enter Sandy Alcantara, the 30-year-old ace who’s battled back from Tommy John surgery in 2024. His 5.36 ERA in 2025 might raise eyebrows, but this is the part most people miss: Alcantara’s performance improved as the season progressed. If the Dodgers want to buy low on a proven talent, now’s the time.
Why is Alcantara’s trade value so low? It boils down to injury concerns. Coming off Tommy John surgery, there’s always the risk of recurrence. However, Alcantara himself feels healthier than he has in years. At Marlins media day, he candidly shared, ‘Coming back from TJ, you’re not going to do great since the first day… I’ve just got to be able to be healthy this year, showing the people in Spring Training that I can do great.’ His stats from 2021 to 2025 tell a story of peaks and valleys, but his potential for a rebound is undeniable.
Here’s the kicker: the Dodgers don’t need a frontline starter—their rotation is already stacked. But this is a franchise that thrives on dominance, not complacency. Instead of waiting for the deadline to chase Skubal or another expiring contract, why not snag Alcantara at a bargain? With his affordable contract (including a club option for 2027) and upside, he’s a low-risk, high-reward play. Pair him with LA’s resources, and you’ve got a recipe for revival.
But here’s the controversial question: Would the Marlins actually make this trade? If I were running the show in Miami, Alcantara would’ve been traded ages ago. By holding onto him post-surgery, the Marlins watched his value plummet. Their best move now is to trade him to a contender on name value alone or gamble on a deadline deal if he rebounds. In return, they could land a versatile arm like Sheehan and a high-ceiling prospect like Tibbs III—a package that balances immediate impact and future potential.
For the Dodgers, this trade isn’t about filling a hole; it’s about elevating an already strong rotation to elite status. While their current staff includes stars like Yoshinobu Yamamoto and Blake Snell, depth is key. Adding Alcantara ensures they’re not just good—they’re championship-ready. And this is where you come in: Do you think the Dodgers should pull the trigger on this deal, or is it too risky? Let’s hear your take in the comments!
